| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 原料药业务(元) | 207,275,090.20 | 410,716,865.23 | 181,914,375.98 | 351,811,465.32 | 171,340,814.12 |
| 制剂业务(元) | 4,865,651.28 | 11,654,559.77 | 5,409,497.31 | 7,992,363.76 | 2,766,415.83 |
| 中间体业务(元) | 28,760,815.93 | 46,830,986.22 | 22,253,143.30 | 34,558,649.75 | 17,344,129.79 |
| 其他(元) | 1,184,302.93 | 2,307,751.13 | 1,059,828.50 | 3,090,791.03 | 1,916,660.89 |
| 营业成本(元) | |||||
| 原料药业务(元) | 115,399,734.73 | 244,345,112.78 | 108,617,015.13 | 207,276,764.42 | 104,419,647.71 |
| 制剂业务(元) | 2,174,682.82 | 5,171,086.60 | 2,095,523.28 | 3,642,236.60 | 928,110.03 |
| 中间体业务(元) | 15,119,325.38 | 23,095,251.36 | 12,093,480.13 | 19,790,906.61 | 11,166,329.63 |
| 其他(元) | 1,606,114.54 | 3,352,091.91 | 1,549,903.54 | 3,474,914.43 | 1,474,633.98 |
| 毛利(元) | |||||
| 原料药业务(元) | 91,875,355.47 | 166,371,752.45 | 73,297,360.85 | 144,534,700.90 | 66,921,166.41 |
| 制剂业务(元) | 2,690,968.46 | 6,483,473.17 | 3,313,974.03 | 4,350,127.16 | 1,838,305.80 |
| 中间体业务(元) | 13,641,490.55 | 23,735,734.86 | 10,159,663.17 | 14,767,743.14 | 6,177,800.16 |
| 其他(元) | -421,811.61 | -1,044,340.78 | -490,075.04 | -384,123.40 | 442,026.91 |
| 毛利率(%) | |||||
| 原料药业务(%) | 44.33 | 40.51 | 40.29 | 41.08 | 39.06 |
| 制剂业务(%) | 55.31 | 55.63 | 61.26 | 54.43 | 66.45 |
| 中间体业务(%) | 47.43 | 50.68 | 45.65 | 42.73 | 35.62 |
| 其他(%) | -35.62 | -45.25 | -46.24 | -12.43 | 23.06 |
| 收入构成(%) | |||||
| 原料药业务(%) | 85.62 | 87.11 | 86.36 | 88.52 | 88.61 |
| 制剂业务(%) | 2.01 | 2.47 | 2.57 | 2.01 | 1.43 |
| 中间体业务(%) | 11.88 | 9.93 | 10.56 | 8.70 | 8.97 |
| 其他(%) | 0.49 | 0.49 | 0.50 | 0.78 | 0.99 |
| 毛利构成(%) | |||||
| 原料药业务(%) | 85.24 | 85.08 | 84.95 | 88.53 | 88.78 |
| 制剂业务(%) | 2.50 | 3.32 | 3.84 | 2.66 | 2.44 |
| 中间体业务(%) | 12.66 | 12.14 | 11.78 | 9.05 | 8.20 |
| 其他(%) | -0.39 | -0.53 | -0.57 | -0.24 | 0.59 |